Development of taste-masking microcapsules containing azithromycin by fluid bed coating for powder for suspension and in vivo evaluation

References

• Ahmed, H.H.B., Badraddin, M.-H.a.-H., and Ahmed, A.a.-E., 2014, Chapter one – azithromycin. In: H.G. Brittain, ed. Profiles of drug substances, excipients and related methodology, vol. 39. Milford, New Jersey, USA: Elsevier, 1–40.
   Google Scholar
• Aleksandra, A. and Katarzyna, W., 2017. Polymers in pharmaceutical taste masking applications. Polimery, 62, 419–427.
   Web of Science ®Google Scholar
• Al-Kasmi, B., et al., 2018. Structural and in vitro in vivo evaluation for taste masking. Expert opinion on drug delivery, 15 (11), 1105–1116.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Division of Health Policy Research, 2000. Periodic survey #44. Patient compliance with prescription regimens. Itasca, Illinois, USA: American Academy of Pediatric.
   Google Scholar
• Anupa, M. and Mohan, K., 2004. Coating compositions for bitterness inhibition. US20050281874A1.
   Google Scholar
• Ayenew, Z., et al., 2009. Trends in pharmaceutical taste masking technologies: a patent review. Recent patents on drug delivery & formulation, 3 (1), 26–39.
   PubMedGoogle Scholar
• Bastiaans, D.E.T., et al., 2017. In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir. British journal of clinical pharmacology, 83 (12), 2789–2797.
   PubMed Web of Science ®Google Scholar
• Bérengère, G., et al., 2003. Helping to choose operating parameters for a coating fluid bed process. Powder technology, 130, 193–198.
   Web of Science ®Google Scholar
• Cima Labs Inc, 2001. Interesting patent about common fluidized bed approaches on taste masking. US6221392.
   Google Scholar
• Douroumis, D., 2007. Practical approaches of taste masking technologies in oral solid forms. Expert opinion on drug delivery, 4 (4), 417–426.
   PubMed Web of Science ®Google Scholar
• Drašković, M., et al., 2017. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug development and industrial pharmacy, 43 (5), 723–731.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency, 2006. Reflection paper: formulations of choice for the paediatric population. London. Contract no.: EMEA/CHMP/PEG/194810/2005.
   Google Scholar
• European Medicines Agency, 2014. Guideline on pharmaceutical development of medicines for paediatric use (EMA/CHMP/QWP/805880/2012 Rev. 2). Contract no.: EMA/CHMP/QWP/805880/2012 Rev. 2.
   Google Scholar
• European Parliament and the Council, 2006. Paediatric Regulation (Regulation (EC) No. 1901/2006. Official journal of the European Union, 49, L378/1.
   Google Scholar
• Evonik Nutrition & Care GMBH, 2023. Eudragit – functional polymers to take control of your release profile. Brochure.
   Google Scholar
• Fiese, E.F. and Steffen, S.H., 1990. Comparison of the acid stability of azithromycin and erythromycin A. Journal of antimicrobial chemotherapy, 25 (Suppl. A), 39–47.
   PubMedGoogle Scholar
• Gouin, S., 2004. Microencapsulation: industrial appraisal of existing technologies and trends. Trends in food science & technology, 15 (7–8), 330–347.
   Web of Science ®Google Scholar
• Hu, X., et al., 2013. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride. AAPS PharmSciTech, 14 (1), 29–37.
   PubMed Web of Science ®Google Scholar
• Hu, L., et al., 2009. Preparation, characterization and taste-masking properties of microspheres containing azithromycin. Journal of pharmacy and pharmacology, 61 (12), 1631–1635.
   PubMed Web of Science ®Google Scholar
• Itoh, A. and Niwa T., Pfizer Inc Pfizer Pharmaceuticals LLC, Apr. 24, 2001. Rapidly releasing and taste-masking pharmaceutical dosage form. US20016221402.
   Google Scholar
• Jalali Rajinder, K. and Deepa, R., 2018. Chapter 20 – generic drug and bioequivalence studies. In: D. Vohora and G. Singh, eds. Pharmaceutical medicine and translational clinical research. Boston: Academic Press, 327–339.
   Google Scholar
• Kharb, V., et al., 2014. Formulation and evaluation of lipid based taste masked granules of ondansetron HCl. European journal of pharmaceutical sciences, 62, 180–188.
   PubMed Web of Science ®Google Scholar
• Kozarewicz, P., 2014. Regulatory perspectives on acceptability testing of dosage forms in children. International journal of pharmaceutics, 469 (2), 245–248.
   PubMed Web of Science ®Google Scholar
• Krise, H.E., Rajendra, K.K., and John, H., 2004. US20046740341.
   Google Scholar
• Lo, J.B., et al., 2009. Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy. Drug development and industrial pharmacy, 35 (12), 1522–1529.
   PubMed Web of Science ®Google Scholar
• Manoj, K.P., Shrikant, B., and Anandi, K., 2004. Improved taste masking pharmaceutical composition and process for its preparation. WO2004066984A2.
   Google Scholar
• Meissonnier, J., Rose, F., and Bohn, M.M., 2006. Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same. 20060233873.
   Google Scholar
• Mennella, J.A. and Bobowski, N.K., 2015. The sweetness and bitterness of childhood: insights from basic research on taste preferences. Physiology & behavior, 152 (Pt B), 502–507.
   PubMedGoogle Scholar
• Qi, H., et al., 2021. In-vitro and in-vivo evaluation of taste-masked ibuprofen formulated in oral dry emulsions. Drug development and industrial pharmacy, 47 (8), 1318–1325.
   PubMed Web of Science ®Google Scholar
• Robert, W.W.S., 1995. Taste masking of ibuprofen by fluid bed coating. 0524180B1.
   Google Scholar
• Sahni, E. and Chaudhuri, B., 2011. Experiments and numerical modeling to estimate the coating variability in a pan coater. International journal of pharmaceutics, 418 (2), 286–296.
   PubMed Web of Science ®Google Scholar
• Saita, M.G., et al., 2018. pH-dependent stability of azithromycin in aqueous solution and structure identification of two new degradation products. Journal of pharmaceutical and biomedical analysis, 158, 47–53.
   PubMed Web of Science ®Google Scholar
• Saurabh, S. and Garima, M., 2010. Fluid bed technology: overview and parameters for process selection. International journal of pharmaceutical sciences and drug research, 2, 236–246.
   Google Scholar
• Seema, T., Thakral, N.K., and Majumdar, D.K., 2013. Eudragit®: a technology evaluation. Expert opinion on drug delivery, 10 (1), 131–149.
   PubMed Web of Science ®Google Scholar
• Stange, U., Christian, F., and Henning, G., 2014. Taste masking of naproxen sodium granules by fluid-bed coating. Pharmaceutical development and technology, 19 (2), 137–147.
   PubMed Web of Science ®Google Scholar
• Tung, N.T., et al., 2018. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets. European journal of pharmaceutics and biopharmaceutics, 126, 187–200.
   PubMed Web of Science ®Google Scholar
• Whitaker, M.J., et al., 2015. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency. Journal of clinical endocrinology and metabolism, 100 (4), 1681–1688.
   PubMed Web of Science ®Google Scholar
• Wolfe, M.M. and Soll, A.H., 1988. The physiology of gastric acid secretion. New England journal of medicine, 319 (26), 1707–1715.
   PubMed Web of Science ®Google Scholar
• Xu, M., Heng, P.W., and Liew, C.V., 2015. Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor. Expert opinion on drug delivery, 12 (10), 1597–1606.
   PubMed Web of Science ®Google Scholar